Federico Mingozzi

Company: Spark Therapeutics
(V)

Job title: Chief Scientific Officer

Seminars:

CNS Immunogenicity & Toxicity Panel 6:00 pm

Discussing the latest CNS immunogenicity data Debating DRG toxicity Translation of toxicity research into the clinicRead more

day: Day One